FDA Approved: EMGALITY — Supplemental Application (Eli Lilly and Company)

View source ↗

Summary

FDA approved a supplemental application for EMGALITY (galcanezumab) by Eli Lilly and Company. The approval covers a change to the product's labeling or indicati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cluster Headache
• Migraine

Drugs mentioned

• Emgality (galcanezumab)

Snippet

SUPPL AP for EMGALITY (GALCANEZUMAB-GNLM)